FDA Inspection
Lohxa LLCLohxa LLC – FDA Inspection, Mar 22, 2019
Record Details
This FDA Inspection record concerns Lohxa LLC, with an inspection on March 22, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 0b79876e-80d0-44e6-82eb-6a79165cc87c
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1083738
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
11- 21 CFR 211.100(a)Changes to Procedures Not Reviewed, Approved
- 21 CFR 211.110(a)Control procedures to monitor and validate performance
- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
- 21 CFR 211.46(b)Equipment for Environmental Control
- 21 CFR 211.186(b)(9)Complete instructions, procedures, specifications et. al.
- 21 CFR 211.130Procedures are written, and followed
- 21 CFR 211.180(c)Records not made readily available to FDA
- 21 CFR 211.68(a)Calibration/Inspection/Checking not done
- 21 CFR 211.160(b)(4)Calibration - at intervals, written program, remedial action
- 21 CFR 211.192Investigations of discrepancies, failures
Showing 10 of 11 citations.
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Lohxa LLC
1| Date | Classification | Office | Project area |
|---|---|---|---|
| April 30, 2025 | Not classified | New England District Office | Drug Quality Assurance |
Other documents for Lohxa LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.